Solventis Wertpapierhandelsbank
Geratherm reported in the H1 report 2014 via a share increase of 2% at apoplex a proceeds gain of 560 t €. The valuation…
Geratherm reported in the H1 report 2014 via a share increase of 2% at apoplex a proceeds gain of 560 t €. The valuation…
The study has been published in the Journal of Clinical and Experimental Cardiology under the title "Extended electrocar…
. - Turnover 17 million EUR + 18,0 % - EBITDA 2,948 kEUR + 13.1 % - EBITDA margin 17.4 % (p.y: 18.1 %) - EBIT 2.4 mi…
Geratherm Medical AG (ISIN: DE0005495626) has successfully completed a capital increase of up to 10% of the existing cap…
The Managing Board of Geratherm Medical AG (ISIN: DE0005495626) received Supervisory Board approval today to carry out a…
/pressemitteilung/pdf/24505/meldung.pdf